• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2023
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: requested, unknown.Age & date of birth: requested, unknown.Patient sex: requested, unknown.Weight: requested, unknown.Ethnicity: requested, unknown.Race: requested, unknown.Implanted date: device was not implanted.Explanted date: device was not explanted.Review of the manufacturing record and shipping inspection record of the actual sample found no anomaly in them.A search of the past complaint file found no similar report on the involved product code/lot number.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.2243441.
 
Event Description
The user facility reported that during emergency cardiovascular care (ecc) that there was plasma leakage after three hours emergency cardiovascular care (ecc).The total emergency cardiovascular care (ecc) was three and a half hours.There was no negative performance impact.The surgery could be finished with the same oxygenator.The procedure was completed successfully, and the patient was not harmed.
 
Manufacturer Narrative
This report is being submitted as follow-up no.1 to update section h3, and to provide the completed investigation results.Review of the provided video: the provided video showed that red transparent liquid was flowing out from gas-out side.Inspection of the actual sample: visual inspection of the actual sample upon arrival at the factory found that: there was no anomaly in the appearance such as a breakage.The entire oxygenation module had discolored to pink.Leak test: the actual sample was cleaned, the blood channel was filled with colored physiological saline solution, the blood outlet port side was blocked, and then air pressure of 2kgf/cm was applied from the blood inlet port.As a result, no leak was observed.According to the results of the investigation, there was no anomaly that could lead to leakage in the actual sample.As for the cause of this incident, since no leakage was observed during the investigation in the cleaned actual sample, the following possibility was considered based on our past experience.However, the cause of the plasma leak could not be clarified.The blood properties changed due to some factors and some substances possessing surfactant property was produced.Owing to such substances, the relationship of the surface tension between the blood and gas, which had been maintained in the micropores of the fiber, was broken, leading to the plasma leak.Ifu states: "a phenomenon called wet lung may occur when water condensation occurs inside fibers of microporous membrane oxygenators with blood flowing exterior to the fibers.This may occur when oxygenators are used for a longer period of time.If water condensation and/or a decrease in pao2 and/or an increase in paco2 is noted during extended oxygenator use, briefly increasing the gas flow rate may improve the performance.Increase gas flow rate, to 20 l/min for 10 seconds.Do not repeat this flushing technique, even if oxygenator performance is not improved." terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
6402040886
MDR Report Key16373046
MDR Text Key309610035
Report Number9681834-2023-00016
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701060
UDI-Public04987350701060
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCX*FX25E
Device Lot Number220907
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/10/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/18/2023
Initial Date FDA Received02/14/2023
Supplement Dates Manufacturer Received02/10/2023
Supplement Dates FDA Received03/09/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-